Wall Street Analysts Predict a 25.67% Upside in Aurora Cannabis (ACB): Here's What You Should Know

Core Viewpoint - Aurora Cannabis Inc. (ACB) shares have increased by 50.8% in the past four weeks, closing at $5.61, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of$7.05, representing a 25.7% upside [1] Price Targets - The average of five short-term price targets ranges from a low of $5.74 to a high of$8.73, with a standard deviation of $1.30, indicating variability among analysts [2] - The lowest estimate suggests a 2.3% increase from the current price, while the highest estimate indicates a 55.6% upside [2] Analyst Consensus and Earnings Estimates - Analysts show strong agreement in revising ACB's earnings estimates higher, which is a positive indicator for potential stock upside [4][9] - The Zacks Consensus Estimate for the current year has increased by 560% due to one estimate moving higher without any negative revisions [10] Zacks Rank - ACB holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside [11] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set accurate targets has been questioned [3][5] - Analysts often set overly optimistic price targets due to business incentives, which can lead to inflated estimates [6] - A low standard deviation among price targets indicates a high degree of agreement among analysts, which can be a starting point for further research [7]